Health2Tech
Phase Capital founder Kavya Sharman explains the difference between techbio and biotech and where GenAI is already changing lab work. We discuss autonomous labs, realistic disease “cure” timelines, and her thesis as an investor.
73 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity Health2Tech-yhteisöön!